STOP PRESS: The IRPB 2014 Draft Programme is now published:
The merging of the IRBD and Winter Workshop on Psychosis recognises that diagnosis rarely follows the theoretical classification which sees Schizophrenia and Bipolar Disorders as two distinct groups. This separation of conditions can create an unnatural and restrictive framework for all stakeholders in patient care.
The new IRPB recognises that several factors have led to a crisis in the definitions of diagnostic boundaries:
1. Genetics - genetic profiling may already be able to help identify individuals who may be at risk of developing psychiatric conditions later in life should environmental contributors intervene
2. Neurobiology, although moving the field on considerably, has not provided a failsafe method of identifying the underlying neurotransmitter issue for all conditions and patients
3. Patients - have more ability to identify their symptoms and realise that they do not fall into prescribed categories making up a disorder specification
4. Analysis of symptom clusters are repeatedly showing considerable overlap and fuzziness between diagnostic categorization
5. Co-morbidity and Dual Diagnosis studies further support these data
6. Pharmaceutical therapies have been shown to work across diagnostic boundaries
7. Individualized treatment protocols providing patients with optimal therapy are becoming a more and more realistic proposition
THE IRPB PROGRAMME
The four day IRPB programme will consist of keynote speeches, workshops, debates and interactive seminars, led by the world’s leading experts in Psychosis and Bipolarity discussing the latest thinking and research. Oral Platform and Poster submissions will be invited across the spectrum of symptoms and symptoms clusters outlined below.
Psychosis; Mania; Bipolar depression; Bipolar spectrum; Schizophrenia; Schizoaffective disorders; Cognitive dysfunction and memory impairment; Agitation; Aggression; Delusional unipolar depression; Major Depressive Disorder; Psychoses associated with neurological conditions such as dementias, Alzheimers disease, Niemann-Pick disease, epilepsies, migraine...; Psychoses associated with organic disorders such as malaria, fevers...; Dual diagnoses eg. addiction and anxiety.
In addition, the Economic Crisis has meant that 'Access and Infrastructure' is now much more limited than it was in the past for many Nation States. This has led to worsening adherence rates, and further difficulties for patients trying to come to terms with an often frightening set of symptoms. The Health Economic impact of a treatment is an increasingly important skill for a clinician to acquire.
All these topics will form the basic framework of the FOUR day conference, and proposals are welcomed on any of these.
The submissions pages are now open. You can now submit a single person session, multi-person symposium, oral platform or Poster abstract.
INTRODUCING THE INTERNATIONAL FORUM OF PSYCHOSIS & BIPOLARITY (IFPB)
The conference also has a new parent Association, the International Forum of Psychosis & Bipolarity (IFPB). You can access all membership benefits, including the Online Learning Library, by joining the IFPB